Scientists from Corning’s biochemical technologies unit have developed a new approach for displaying functional membrane proteins on surfaces that may allow for the rapid screening of drug targets against this important class of “druggable” proteins. Their paper, published in the March 20 issue of Journal of the American Chemical Society, is the first demonstration of a protein membrane array and how it might be used in ligand screening, the researchers said.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.